Condition: ADHD · Autism Spectrum Disorder · Sponsor: Daniel Coury
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.
This description comes directly from the study's public registry record.
Amanda James, BS · (614) 722-4006 · Amanda.James@nationwidechildrens.org
Samantha Sharpe · (614) 722-8509 · Samantha.Sharpe@nationwidechildrens.org
Always discuss trial participation with your own doctor first.
| University of California, Irvine | Irvine, California, United States | Recruiting |
| Children's Hospital Los Angeles | Los Angeles, California, United States | Recruiting |
| Maine Medical Center | Portland, Maine, United States | Recruiting |
| Massachusetts General Hospital Lurie Center for Autism | Boston, Massachusetts, United States | Recruiting |
| University of Rochester | Rochester, New York, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
| University of Alberta, Glenrose Rehabilitation Hospital | Edmonton, Canada | Recruiting |
| Holland Bloorview Kids Rehabilitation Hospital | Toronto, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05916339